E2F4 and Alzheimer disease: Therefore, our results suggest that E2F4 phosphorylation in AD favors a pathological phenotype, which is consistent with the phosphorylation observed in the cerebral cortex of h5xFAD mice (Fig. S7a), whereas the expression of dephosphorylated form of hE2F4 reverses this situation.